Security key
896438504
TRINITY BIOTECH PLC - Class A Ordinary Shares, $0.0001 par value per share (TRIB)
CUSIP: 896438504
Q2 2026 13F Holders as of 30 Jun 2026
- Security type / class
- Equity / Class A Ordinary Shares, $0.0001 par value per share
- Total 13F shares
- 993,037
- Total 13F value
- $379,459
- Share change
- -80,033
- SEC-reported price per share
- $0.39
- Number of holders
- 19
- Value change
- -$73,279
- Number of buys
- 7
- Number of sells
- 9
- Shares outstanding
- 34,586,060,172
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2026
Institutions
19
Top holders
10
TRIB full security history
Ownership snapshot
Full 13F holder table
TRINITY BIOTECH PLC SEC filings
TRINITY BIOTECH PLC company facts
Broader feeds
Ownership snapshot
Top reported holders of TRIB - TRINITY BIOTECH PLC - Class A Ordinary Shares, $0.0001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
MiCo IVD Holdings, LLC
Disclosed value leader
PERCEPTIVE ADVISORS LLC
Comparable rows
15/15
Latest evidence
30 Apr 2026
13D/G
13F
Lead comparable stake: 17%
13D/G row: MiCo IVD Holdings, LLC
Showing 1-6 of 15 holder rows.
Quick read
MiCo IVD Holdings, LLC leads the comparable SEC ownership view at 17%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens MiCo IVD Holdings, LLC's linked filing trail.
Comparable ownership
Top 5
MiCo IVD Holdings, LLC
17%
PERCEPTIVE ADVISORS LLC
9.9%
Novus Diagnostics Ltd.
6%
HUNTER ASSOCIATES INVESTMENT MANA...
0%
Yorkville Advisors Global, LP
0%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| MiCo IVD Holdings, LLC |
13D/G
|
17%
|
$62,505,648
69,450,720 shares
|
$0 | 08 Dec 2025 |
| PERCEPTIVE ADVISORS LLC |
13D/G
|
9.9%
|
$2,431,054,169
3,424,019,957 shares
|
+$1,392,282,813 | 30 Apr 2026 |
| Novus Diagnostics Ltd. |
13D/G
|
6%
|
—
1,119,988 shares
|
$0 | 23 Dec 2025 |
| HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC |
13F
Company
|
0%
|
$292,000
536,210 shares
|
— | 31 Mar 2026 |
| Yorkville Advisors Global, LP |
13F
Company
|
0%
|
$121,995
225,000 shares
|
— | 31 Mar 2026 |
| Williams & Novak Wealth Management, LLC |
13F
Company
|
0%
|
$64,371
107,643 shares
|
— | 31 Mar 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
19
Shares
993,037
Rows available
19
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2026 vs Q1 2026 Across Filers
Q1 2026 holders
23
Q2 2026 holders
19
Holder diff
-4
| Investor | Q1 2026 Shares | Q2 2026 Shares | Share Diff | Share Chg % | Q1 2026 value | Q2 2026 value | Value change | Value Chg % |
|---|